zdorПроблемы здоровья и экологииHealth and Ecology Issues2220-09672708-6011Gomel State Medical University10.51523/2708-6011.2008-5-3-8zdor-722Research ArticleКЛИНИЧЕСКАЯ МЕДИЦИНАCLINICAL MEDICINEВИЧ-АССОЦИИРОВАННЫЙ ТУБЕРКУЛЕЗ (литературный обзор)HIV-ASSOCIATED TUBERCULOSIS (literature rewiew)БондаренкоВ. Н.BondarenkoV. N.noemail@neicon.ruРузановД. Ю.RuzanovD. J.noemail@neicon.ruГомельский государственный медицинский университетGomel State Medical University200828092008034146Copyright © Бондаренко В.Н., Рузанов Д.Ю., 20082008Бондаренко В.Н., Рузанов Д.Ю.Bondarenko V.N., Ruzanov D.J.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.gsmu.by/jour/article/view/722

Приведены современные данные по эпидемиологии, патогенезу, клинике и диагностике ВИЧ-ассоциированного туберкулеза. Описаны схемы сочетанной терапии при двойной инфекции ВИЧ/ТБ, схемы химиопрофилактики латентного туберкулеза.

The review dedicated to a problem of a tuberculosis at the HIV-infected persons. The modern data on epidemiology, pathogenesis, clinic and diagnostics of the HIV-associated tuberculosis are resulted. The article described treatment HIV/ТB-infection, chemoprophylaxis the latent tuberculosis.

ВИЧ-инфекциятуберкулезВИЧ-оппортунистические инфекцииHIV-infectiontuberculosisHIV-opportunistic infectionsReferencesКлинико-иммунологические особенности течения туберкулеза в сочетании с ВИЧ-инфекцией / Р. Ш. Валиев [и др.] // Проблемы туберкулеза и болезней легких. ¾ 2005. - № 10. - С. 31-34.Клинико-иммунологические особенности течения туберкулеза в сочетании с ВИЧ-инфекцией / Р. Ш. Валиев [и др.] // Проблемы туберкулеза и болезней легких. ¾ 2005. - № 10. - С. 31-34.Раннее выявление и профилактика туберкулеза у ВИЧ-инфицированных / М. П. Ворожцова [и др.] // Проблемы туберкулеза и болезней легких. - 2005. - № 10. - С. 45-46.Раннее выявление и профилактика туберкулеза у ВИЧ-инфицированных / М. П. Ворожцова [и др.] // Проблемы туберкулеза и болезней легких. - 2005. - № 10. - С. 45-46.Ерохин, В. В. Особенности выявления, клинических проявлений и лечения туберкулеза у ВИЧ-инфицированных / В. В. Ерохин, З. Х. Корнилова, Л. П. Алексеева // Проблемы туберкулеза и болезней легких. - 2005. - № 10. - С. 20-28.Ерохин, В. В. Особенности выявления, клинических проявлений и лечения туберкулеза у ВИЧ-инфицированных / В. В. Ерохин, З. Х. Корнилова, Л. П. Алексеева // Проблемы туберкулеза и болезней легких. - 2005. - № 10. - С. 20-28.Каpачунский, М. А. Тубеpкулез пpи ВИЧ-инфекции / М. А. Каpачунский // Проблемы туберкулеза. - 2000. - № 1. - С. 47-52.Каpачунский, М. А. Тубеpкулез пpи ВИЧ-инфекции / М. А. Каpачунский // Проблемы туберкулеза. - 2000. - № 1. - С. 47-52.Туберкулез у ВИЧ-инфицированных и больных СПИДом / А. Г. Рахманова [и др.] // Клиническая медицина. - 2003. - № 12. - С. 71-73.Туберкулез у ВИЧ-инфицированных и больных СПИДом / А. Г. Рахманова [и др.] // Клиническая медицина. - 2003. - № 12. - С. 71-73.Щелканова, А. И. Особенности течения туберкулеза, сочетанного с ВИЧ-инфекцией / А. И. Щелканова, А. В. Кравченко // Терапевтический архив. - 2004. - № 4. - С. 20-25.Щелканова, А. И. Особенности течения туберкулеза, сочетанного с ВИЧ-инфекцией / А. И. Щелканова, А. В. Кравченко // Терапевтический архив. - 2004. - № 4. - С. 20-25.American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Treatment of Tuberculosis // Am. J. Respir. Crit. Care Med. - 2003. - № 167. - Р. 603-662.American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Treatment of Tuberculosis // Am. J. Respir. Crit. Care Med. - 2003. - № 167. - Р. 603-662.Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-gamma test / I. Brock [et al.] // Respir. Res. - 2006. - № 7. - Р. 56.Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-gamma test / I. Brock [et al.] // Respir. Res. - 2006. - № 7. - Р. 56.Caminero, J. A. World Health Organization; American Thoracic Society; British Thoracic Society. Treatment of multidrug-resistant tuberculosis: evidence and controversies / J. A. Caminero // Int. J. Tuberc. Lung. Dis. - 2006. - № 10. - Р. 829-837.Caminero, J. A. World Health Organization; American Thoracic Society; British Thoracic Society. Treatment of multidrug-resistant tuberculosis: evidence and controversies / J. A. Caminero // Int. J. Tuberc. Lung. Dis. - 2006. - № 10. - Р. 829-837.Cecchini, D. Tuberculous meningitis in HIV-infected patients: drug susceptibility and clinical outcome / D. Cecchini, J. Ambrosioni, C. Brezzo // AIDS. - 2007. - № 21. - Р. 373-374.Cecchini, D. Tuberculous meningitis in HIV-infected patients: drug susceptibility and clinical outcome / D. Cecchini, J. Ambrosioni, C. Brezzo // AIDS. - 2007. - № 21. - Р. 373-374.Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. // MMWR. - 2000. - № 49 (№RR-6). - Р. 1-51.Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. // MMWR. - 2000. - № 49 (№RR-6). - Р. 1-51.HIV Infection and Multidrug-Resistant Tuberculosis - the Perfect Storm / D. Charles [et al.] // The Journal of Infectious Diseases - 2007. - № 196. - Р. 86-107.HIV Infection and Multidrug-Resistant Tuberculosis - the Perfect Storm / D. Charles [et al.] // The Journal of Infectious Diseases - 2007. - № 196. - Р. 86-107.Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection // MMWR. - 2000. - № 49 (No.RR-6). - Р. 1-51.Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection // MMWR. - 2000. - № 49 (No.RR-6). - Р. 1-51.Human immunodeficiency virus type 1 (HIV-1) quasispecies at the sites of Mycobacterium tuberculosis infection contribute to systemic HIV-1 heterogeneity / K. Collins [et al.] // J. Virol. - 2002. - № 76:4. - Р. 1697-1706.Human immunodeficiency virus type 1 (HIV-1) quasispecies at the sites of Mycobacterium tuberculosis infection contribute to systemic HIV-1 heterogeneity / K. Collins [et al.] // J. Virol. - 2002. - № 76:4. - Р. 1697-1706.Daley, C. L. The typically «atypical» radiographic presentation of tuberculosis in advanced HIV disease / C. L. Daley // Tuber. Lung. Dis. - 1995. - № 76. - Р. 475-476.Daley, C. L. The typically «atypical» radiographic presentation of tuberculosis in advanced HIV disease / C. L. Daley // Tuber. Lung. Dis. - 1995. - № 76. - Р. 475-476.Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy / G. L. Dean [et al.] // AIDS. - 2002. - № 16 - Р. 75-83.Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy / G. L. Dean [et al.] // AIDS. - 2002. - № 16 - Р. 75-83.Performance of a T-cell-based diagnostic test for tuberculosis infection in HIV-infected individuals is independent of CD4 cell count / K. Dheda [et al.] // AIDS. - 2005. - № 19. - P. 2038-2041.Performance of a T-cell-based diagnostic test for tuberculosis infection in HIV-infected individuals is independent of CD4 cell count / K. Dheda [et al.] // AIDS. - 2005. - № 19. - P. 2038-2041.Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study / G. Ferrara [et al.] // Lancet. - 2006. - № 367. - P. 1328-1334.Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study / G. Ferrara [et al.] // Lancet. - 2006. - № 367. - P. 1328-1334.Tuberculin Skin Testing in Patients with HIV Infection: Limited Benefit of Reduced Cutoff Values / G. Frank [et al.] // Clinical Infectious Diseases Sep. 1. - 2006. - № 43. - P. 634-639.Tuberculin Skin Testing in Patients with HIV Infection: Limited Benefit of Reduced Cutoff Values / G. Frank [et al.] // Clinical Infectious Diseases Sep. 1. - 2006. - № 43. - P. 634-639.Effectiveness of Isoniazid Treatment for Latent Tuberculosis Infection among Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Injection Drug Users in Methadone Programs / N. Jerod [et al.] // Clinical Infectious Diseases. - 2003. - № 37. - P. 1686-1692.Effectiveness of Isoniazid Treatment for Latent Tuberculosis Infection among Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Injection Drug Users in Methadone Programs / N. Jerod [et al.] // Clinical Infectious Diseases. - 2003. - № 37. - P. 1686-1692.Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infections / B.E. Jones [et al.] // Am. Rev. Respir. Dis. - 1993. - № 148. - P. 1292-1297.Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infections / B.E. Jones [et al.] // Am. Rev. Respir. Dis. - 1993. - № 148. - P. 1292-1297.Manifestations and outcome of extra-pulmonary tuberculosis: impact of human immunodeficiency virus co-infection / Е. Kwara [et al.] // Int. J. Tuberc. Lung. Dis. - 2005. - № 9. - P. 485-493.Manifestations and outcome of extra-pulmonary tuberculosis: impact of human immunodeficiency virus co-infection / Е. Kwara [et al.] // Int. J. Tuberc. Lung. Dis. - 2005. - № 9. - P. 485-493.Lipman, M. Immune reconstitution inflammatory syndrome in HIV / M. Lipman, R. Breen // Curr. Opin. Infect. Dis. - 2006. - № 19. - P. 20-25.Lipman, M. Immune reconstitution inflammatory syndrome in HIV / M. Lipman, R. Breen // Curr. Opin. Infect. Dis. - 2006. - № 19. - P. 20-25.Increased survival of persons with tuberculosis and human immunodeficiency virus infection, 1991-2000 / M. K. Leonard [et al.] // Clin. Infect. Dis. - 2002. - № 34:7. - P. 1002-1007.Increased survival of persons with tuberculosis and human immunodeficiency virus infection, 1991-2000 / M. K. Leonard [et al.] // Clin. Infect. Dis. - 2002. - № 34:7. - P. 1002-1007.Schluger, N. W. Recent advances in our understanding of human host responses to tuberculosis / N. W. Schluger // Respir. Res. - 2001. - № 2:3. - P.157-163.Schluger, N. W. Recent advances in our understanding of human host responses to tuberculosis / N. W. Schluger // Respir. Res. - 2001. - № 2:3. - P.157-163.World Health Organization. Treatment of tuberculosis. Guidelines for National Programmes. - Geneva, 2003. - WHO/CDS/TB/2003. - Р. 313.World Health Organization. Treatment of tuberculosis. Guidelines for National Programmes. - Geneva, 2003. - WHO/CDS/TB/2003. - Р. 313.World Health Organization. TB/HIV. A clinical manual. - Geneva, 2004. - WHO/HTM/TB/2004. - Р. 329.World Health Organization. TB/HIV. A clinical manual. - Geneva, 2004. - WHO/HTM/TB/2004. - Р. 329.World Health Organization. The Stop TB strategy. Building on and enhancing DOTS to meet the TB-related Millennium Development Goals. - Geneva, 2006. - WHO/HTM/STB/2006. - Р. 37.World Health Organization. The Stop TB strategy. Building on and enhancing DOTS to meet the TB-related Millennium Development Goals. - Geneva, 2006. - WHO/HTM/STB/2006. - Р. 37.World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. - Geneva, 2006. ¾ WHO/HTM/TB/2006. - Р. 361.World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. - Geneva, 2006. ¾ WHO/HTM/TB/2006. - Р. 361.

The authors declare that there are no conflicts of interest present.